Zai Lab Limited American Depositary Shares (ZLAB)
PHARMACEUTICAL PREPARATIONS
Zai Lab Limited American Depositary Shares (ZLAB) is listed on Nasdaq, where it has traded since September 20, 2017.
- Listed On
- Nasdaq
- Listed Since
- September 20, 2017
- Employees
- 1,797
- Market Cap
- $2.9B
About Zai Lab Limited American Depositary Shares
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 90 institutions reported holding ZLAB, with 42.7 million shares worth $811.7 million in aggregate. The largest reported holder was Rtw Investments, with 6.6 million shares worth $124.9 million. Of the 5 largest holders listed below, 1 opened a new position in ZLAB, 3 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Rtw Investments | 6,574,032 | $125M | Unchanged |
| Tcg Crossover Management | 6,137,627 | $117M | New position |
| RA Capital Management | 5,743,533 | $109M | Added 0.64% |
| Adar1 Capital Management | 3,369,034 | $64M | Added 136.36% |
| FMR | 2,815,214 | $53M | Added 123.01% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ZLAB?
Zai Lab Limited American Depositary Shares (ZLAB) is listed on Nasdaq, where it has traded since September 20, 2017.
Who are the largest institutional holders of ZLAB?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of ZLAB were Rtw Investments, Tcg Crossover Management and RA Capital Management.
How many institutions own ZLAB?
90 institutions reported a position in ZLAB for the quarter ended June 30, 2026, worth $811.7 million in total.
Did institutions buy or sell ZLAB last quarter?
Of the 5 largest reported holders, 1 opened a new position in ZLAB, 3 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for ZLAB.
Every reported institutional holder, plus insider and congressional trades in ZLAB, on SentiSense.